patients. 4 Because of the high prevalence of these deficits, and their impact on quality of life, the American Heart Association (AHA) and the American Academy of Pediatrics (AAP) now recommend systematic evaluation of development in children with CHD throughout childhood to promote early detection of delays and optimize outcomes. 1 Cardiac centers have begun to incorporate developmental follow-up programs as part of routine cardiac care. [12] [13] [14] However, few centers have reported outcomes for patients seen in these programs, and little is known about whether early developmental evaluations performed in these clinics can predict later outcomes.
We have previously reported developmental outcomes of children who were evaluated in our longitudinal developmental followup program over the first 3 years of life, and found that delays were common, but the pattern of delays changed over time. 15, 16 We have also reported ND outcomes for preschool-aged children seen in our program, and found that deficits for preschoolers with CHD without genetic conditions were mild, and may not be detected without formal testing. 17 The aim of this study was to investigate the relationship between ND test scores at 2 and 4 years of age, and determine whether rates of ND problems change over time, and whether developmental evaluations at age 2 could predict ND outcomes at age 4.
| ME THODS

| Patient population
Children with CHD believed to be at high risk of developmental delay as defined by the AHA/AAP guideline 1 were recruited from the Herma Heart Center Developmental Follow-up Clinic (HHCDC) at
Children's Hospital of Wisconsin (CHW, Figure 1 ). Eligibility criteria and operation of the HHCDC have been previously described.
12,15-17
Children with CHD were seen for serial developmental evaluations, approximately every 6 months, between 6 months and 3 years of age. Families were then contacted by letter to schedule a subsequent developmental evaluation when the child reached 4-6 years of age.
Children were seen for ND testing within the cardiology clinic; ap- 
| Measures
At the 24 ± 3 months of age assessment, children completed the Parents completed a basic demographic form which provided information about parental education and occupation, as well as family structure and the child's history of participation (past or present) in early intervention services (speech, physical, and/or occupational therapy). Information regarding patient and treatment characteristics was abstracted from the medical record. Pearson intervals. A two-sided P value of <.05 was considered as significant. All statistical analyses were performed using SAS version 9.4 (SAS Institute, Cary, North Carolina) software.
| Statistical analysis
F I G U R E 1 Herma Heart Center Developmental Follow-up Clinic (HHCDC) patients. Shaded box identifies current study cohort. Abbreviations: CHD, congenital heart disease; ND, neurodevelopmental
| RE SULTS
From March 2011 through August 2016, 141 subjects with pediatric heart disease completed preschool ND testing ( Figure 1 ). Of these, 105 (74.5%) had been seen in the 0-3 clinic; 64 (45.4%) had a developmental evaluation at 24 ± 3 months of age.
Characteristics of the sample are presented in Table 1 . Median age at preschool assessment was 4.4 years (IQR 4.3-4.7 years). Anatomy was classified according to the child's fundamental diagnosis at birth.
Thirty percent of the subjects had anatomy that required surgical palliation resulting in a functional single ventricle (1V). Twenty-three percent (n = 15) of the subjects had a known medical comorbidity, in addition to their CHD, involving the following systems: airway (n = 7), gastrointestinal/genitourinary (n = 2), hearing (n = 1), neurologic (n = 1), chronic lung disease (n = 1), multisystem (n = 2), and orthopedic (n = 1). Twenty-two percent (n = 14) of the subjects had a diag- one subject with tricuspid atresia had Williams syndrome.
Subject and treatment characteristics at the time of assessment are presented in Table 2 . All subjects had undergone a surgical or catheter-based cardiac intervention within the first year of life, making them eligible for the developmental follow-up program.
The majority of subjects, 59/64 (92%) had undergone at least one heart surgery requiring cardiopulmonary bypass (CPB), and 24/64 (38%) had undergone deep hypothermic circulatory arrest (DHCA).
A majority of subjects, 59/64 (92%), had received early intervention services (eg, physical, occupational, or speech therapy) previously, but only 29/64 (45%) were currently enrolled in early intervention services at the time of their preschool evaluation.
The mean BSID-III cognitive composite score at age 2 was 94.5
(SD = 21.2). The mean WPSSI-III/IV Full Scale IQ score at age 4 was 93.1 (SD = 21.1). Scores were significantly correlated; Pearson r = .80, P < .0001. The mean BSID-III fine motor scaled score (age 2) was 9.6 (SD = 3.7). The mean WRAVMA Pegboard standard score (age 4) was 86.4 (SD = 18.6). Scores were significantly correlated,
Pearson r = .75, P < .0001.
The percentages of the subjects that fell within the average (within 1 SD of test norm), at risk (1-2 SD from test norm) and delayed (>2 SD from test norm) ranges at age 2 vs age 4 are illustrated in Figure 2 (cognitive scores) and Figure 3 (fine motor scores). There was 78.6% agreement in cognitive score categories (average, at risk, delayed); more patients were at risk at age 4 vs age 2 (P = .007). There was 61% agreement in fine motor score categories; more patients were at risk or delayed at age 4 vs age 2 (P < .001). At both age 2 and age 4, there were more children in the delayed category for cognitive scores if they had a genetic condition (P < .0001). For fine motor scores, at age 2, there were more children in the average category if they had no/other medical conditions compared with those who had a genetic condition (P < .0001). At age 4, for fine motor scores, there were more children in the delayed category if they had a genetic condition.
Sensitivities, specificities, and positive and negative predictive values were calculated and are reported in Table 3 . The positive Twenty-four subjects had DHCA.
TA B L E 1 Sample demographics (N = 64)
TA B L E 2 Subject and treatment characteristics
predictive value of a BSID-III score that was at risk or delayed (>1 SD below the mean) to predict a similar score at age 4 was 100% for both cognitive and fine motor skills. For children who scored in the at risk or delayed range at age 4, the sensitivity of the BSID-III to detect a similar delay at age 2 was 33% with 95% CI (15.6%, 55.3%) for fine motor and 50% with 95% CI (28.2%, 71.8%) for cognitive skills.
| D ISCUSS I ON
Consistent with previous research on ND outcomes in children with CHD, 15, 16, 22, 23 results of the current study indicate that rates of delay for children with CHD change over time. Although there were statistically significant correlations between scores at age 2 and age 4, more children in the current study fell in the at risk or delayed category at age 4 compared with age 2 for both cognitive and fine motor skills. This is in contrast to findings from other studies that found improved cognitive scores over time. 24, 25 Creighton et al 24 studied
neurocognitive outcomes in children with complex CHD at age 2 and age 5 and found that fewer children were delayed at 5 years than at 2 years. These findings may differ from the current study due to the use of different ND measures. In addition, Creighton et al 24 excluded
patients with chromosomal abnormalities, whereas the current study included scores from these children. Because children with CHD and comorbid genetic conditions do meet the AHA/AAP 1 criteria regarding which children should be referred for repeated ND assessment, we felt that it was important to include them in our results. Results of the current study suggest that delays detected by the BSID-III at age 2 likely reflect "true" delays that continue to age 4.
Bode et al
However, the sensitivity of the BSID-III was only 33% for fine motor skills and 50% for cognitive skills, suggesting that the BSID-III has a high rate of false negatives. This is consistent with other studies that have shown that the BSID-III underestimates rates of delay when compared with earlier versions of the measure. 26, 27 Parents and practitioners should be cautioned that an average score on the BSID-III does not rule out the possibility for later delays. Because some problems in children with CHD may not present until later childhood or adolescence (eg, deficits in executive functioning, social cognition), comprehensive, longitudinal ND assessment is recommended.
There are some important limitations to the current study.
Results are based on a small sample size from a single center; thus, results may not generalize to the CHD population as a whole. In addition, we were not able to quantify additional factors that occurred between the two ND assessments that may have exposed patients to further developmental risk. Finally, a high percentage of patients had participated in early intervention services in the past, and almost a half of them were receiving early intervention services at the time of the 4-year-old assessment; what impact those services had on ND outcomes is not known.
F I G U R E 2 Percent of patients in the average, at risk, or delayed range for cognitive scores at age 2 years vs age 4 years F I G U R E 3 Percent of patients in the average, at risk, or delayed range for fine motor scores at age 2 years vs age 4 years 
| CON CLUS IONS
